Moderate-severe obstructive sleep apnea and the risk for preclinical Alzheimer's disease biomarkers changes
This study aimed at identify the preclinical alterations of sleep, neuropsychological, cerebrospinal-fluid, and 2-deoxy-2-(18F)fluoro-D-glucose positron emission tomography ([18F]FDG PET) in OSA patients.
Source: Sleep Medicine - Category: Sleep Medicine Authors: L. Mari, B. Paoli, A. Chiaravalloti, F. Placidi, F. Izzi, A. Pisani, N. Manfredi, A. D'Elia, O. Schillaci, N.B. Mercuri, C. Liguori Tags: Sleep Breathing Disorders Source Type: research
More News: Alzheimer's | Brain | Neurology | Obstructive Sleep Apnea | PET Scan | Sleep Apnea | Sleep Disorders | Sleep Medicine | Study